We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

196 hedge funds and large institutions have $2.65B invested in Axonics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 79 increasing their positions, 60 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 18

32% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 60

5% more funds holding

Funds holding: 186196 (+10)

7% less capital invested

Capital invested by funds: $2.84B → $2.65B (-$194M)

85% less call options, than puts

Call options by funds: $3.94M | Put options by funds: $26.5M

Holders
196
Holders Change
+10
Holders Change %
+5.38%
% of All Funds
3.3%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
30
Increased
79
Reduced
60
Closed
18
Calls
$3.94M
Puts
$26.5M
Net Calls
-$22.6M
Net Calls Change
-$20M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$193M -$3.22M -58,753 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$175M +$14.7M +268,555 +10%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$163M -$28.1M -513,175 -15%
BG
4
Bellevue Group
Switzerland
$131M +$14.5M +264,647 +13%
BAMCO Inc
5
BAMCO Inc
New York
$104M +$8.4M +153,200 +9%
Axa
6
Axa
France
$101M -$2.83M -51,709 -3%
Ameriprise
7
Ameriprise
Minnesota
$93.6M +$14M +254,870 +18%
CS
8
Credit Suisse
Switzerland
$91.5M -$15.9M -290,663 -15%
Loomis, Sayles & Company
9
Loomis, Sayles & Company
Massachusetts
$86.7M -$490K -8,937 -0.6%
Invesco
10
Invesco
Georgia
$76.6M +$9.88M +180,185 +15%
Lord, Abbett & Co
11
Lord, Abbett & Co
New Jersey
$71.4M +$958K +17,469 +1%
HRCM
12
Hood River Capital Management
Florida
$68.3M +$8.07M +147,246 +14%
RI
13
RTW Investments
New York
$66.9M -$30.9M -563,899 -32%
Norges Bank
14
Norges Bank
Norway
$62M +$33.8M +616,872 +129%
CIP
15
Champlain Investment Partners
Vermont
$61.9M +$5.36M +97,760 +10%
State Street
16
State Street
Massachusetts
$56.9M -$425K -7,749 -0.8%
Macquarie Group
17
Macquarie Group
Australia
$56.5M +$291K +5,308 +0.5%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$47.4M +$30.6K +559 +0.1%
Neuberger Berman Group
19
Neuberger Berman Group
New York
$46.9M +$6.1M +111,201 +16%
Millennium Management
20
Millennium Management
New York
$38.8M -$4.98M -90,779 -12%
Northern Trust
21
Northern Trust
Illinois
$36.2M -$739K -13,483 -2%
Goldman Sachs
22
Goldman Sachs
New York
$33.5M +$1.48M +27,017 +5%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$30.1M -$6.49M -118,340 -18%
Marshall Wace
24
Marshall Wace
United Kingdom
$29.2M -$27.8M -507,339 -50%
Amundi
25
Amundi
France
$28.3M -$1.21M -22,018 -5%

AXNX Hedge Fund Activity: Q2 2022 in Review

196 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q2 2022, worth a combined $2.65B — down 6.8% from $2.84B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new AXNX positions and 18 closed out — a net gain of 12 holders — while 79 added to existing stakes and 60 trimmed.

The largest buyer was Norges Bank, adding an estimated $33.8M. The largest seller was RTW Investments, cutting an estimated $30.9M.

  • 196 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q2 2022, up from 186 in Q1 2022.
  • Funds reported $2.65B of Axonics, Inc. Common Stock stock for Q2 2022, down 6.8% quarter-over-quarter.
  • 30 funds opened new Axonics, Inc. Common Stock positions in Q2 2022 and 18 closed out, a net change of +12 holders.
  • The largest Axonics, Inc. Common Stock buyer in Q2 2022 was Norges Bank, an estimated $33.8M added.
  • The largest Axonics, Inc. Common Stock seller in Q2 2022 was RTW Investments, an estimated $30.9M sold.

Based on aggregated 13F filings for Q2 2022.